Literature DB >> 10930595

Cervical cord magnetic resonance imaging findings in systemic immune-mediated diseases.

M Rovaris1, B Viti, G Ciboddo, R Capra, M Filippi.   

Abstract

Brain magnetic resonance imaging (MRI) findings in patients with systemic immune-mediated diseases (SID) affecting the central nervous system (CNS) are heterogeneous and lack diagnostic specificity. In the present study, we evaluated the potential role of cervical cord MRI for increasing confidence when making a diagnosis of SID. Sagittal, T2-weighted images of the cervical cord were obtained in patients affected by systemic lupus erythematosus (SLE) with (NSLE, n=9) and without clinical CNS involvement (n=15), Behçet disease (BD, n=5), Wegener granulomatosis (WG, n=9), antiphospholipid antibody syndrome (APLAS, n=6) and multiple sclerosis (MS, n=10). Spinal cord hyperintense lesions were found in 9/10 MS patients, while no lesions were visible in the cervical cord of any patient with SID, regardless of the presence or absence of brain abnormalities. Cervical cord MRI can be useful in diagnosing patients suspected of having a SID.

Entities:  

Mesh:

Year:  2000        PMID: 10930595     DOI: 10.1016/s0022-510x(00)00325-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome.

Authors:  M Rovaris; C Pedroso; M Filippi
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  B Cesar; M G Dwyer; J L Shucard; P Polak; N Bergsland; R H B Benedict; B Weinstock-Guttman; D W Shucard; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-11       Impact factor: 3.825

3.  Neurological manifestations of connective tissue diseases mimicking multiple sclerosis.

Authors:  Sigliti-Henrietta Pelidou; Sotiris Giannopoulos; Sotiria Tzavidi; Niki Tsifetaki; Georgios Kitsos; Dimitrios Stefanou; Vassiliki Kostadima; Alexandros A Drosos; Athanassios P Kyritsis
Journal:  Rheumatol Int       Date:  2007-06-15       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.